Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach

Oncology

Volumn 66, Issue 5, 2004, Pages 379-387

  Sasaki, Atsunori ^a   Kitadai, Yasuhiko ^a   Ito, Masanori ^a   Tanaka, Shinji ^b   Yoshihara, Masaharu ^a   Haruma, Ken ^c   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Background mucosa; Gastric carcinoma; HIK1083; Human gastric mucin; MUC2; Mucin phenotype; Pepsinogen; Small intestinal mucinous antigen

Indexed keywords

HUMAN GASTRIC MUCIN ANTIBODY; MONOCLONAL ANTIBODY; PEPSINOGEN I; PEPSINOGEN II; STOMACH MUCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ATROPHY; BACTERIUM DETECTION; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; FREQUENCY ANALYSIS; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; STOMACH MUCOSA; TUMOR CELL; TUMOR CLASSIFICATION;

ADENOCARCINOMA; AGED; FEMALE; GASTRIC MUCIN; GASTRIC MUCOSA; GASTRITIS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINES; MALE; MIDDLE AGED; MUCINS; PHENOTYPE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 4444243680     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079486     Document Type: Article

References (49)

1. Lauren P: The two histological main types of gastric carcinoma: Diffuse type and so-called intestinal type carcinoma. An attempt at a histological classification. Acta Pathol Microbiol Scand 1965;64:31-49.
2. Nakamura K, Sugano H, Takagi K: Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. GANN 1968;59;251-258.
3. Nakamura K: Special features of intestinal metaplasia and its relation to early gastric carcinoma in man: Observation by a method in which leucine aminopeptidase activity is used. J Natl Cancer Inst 1978;61:693-701.
4. Nakamura K, Sugano H, Takagi K, Kumakura K: Histogenesis of cancer of the stomach, with special reference to light and electron microscopic and statistical studies of primary microcarcinoma of the stomach. Gan No Rinsho 1969;15:627-647.
5. Nagayo T: Microscopical cancer of the stomach: A study on histogenesis of gastric carcinoma. Int J Cancer 1975;16:52-60.
6. Fiocca R, Villani L, Tenti P, Solcia E, Cornaggia M, Frigerio B, Capella C: Characterization of 4 main cell types in gastric cancer: Foveolar, mucopeptic, intestinal columnar and goblet cells. A histopathologic, histochemical and ultrastructual study of early and advanced tumours. Pathol Res Pract 1987;182:308-325.
7. Sepulveda AR, Wu L, Ota H, Gutierrez O, Kim JG, Genta RM, Graham DY: Molecular identification of main cellular lineages as a tool for the classification of gastric cancer. Hum Pathol 2000;31:566-574.
8. Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simoes M: Gastric carcinoma exhibits distinct types of cell differentiation: An immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 2000;190:437-443.
9. Correa P: A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-3560.
10. Correa P: Human gastric carcinogenesis: A multistep and multifactorial process-first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-6740.
11. Correa P, Shiao YH: Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994;54:1941-1943.
12. Sipponen P, Kekki M, Siurala M: Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma: Comparison with a representative population sample. Cancer 1983;52:1062-1068.
13. Sasaki I, Yao T, Nawata H, Tsuneyoshi M: Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development. Cancer 1999;85:1719-1729.
14. Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N: Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990;40:494-504.
15. Egashira Y, Shimoda T, Ikegami M: Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int 1999;49:55-61.
16. Endoh Y, Tamura G, Watanabe H, Ajioka Y, Motoyama T: The common 18-base pair deletion at codons 418-423 of the E-cadherin gene in differentiated-type adenocarcinomas and intramucosal pre-cancerous lesions of the stomach with the features of gastric foveolar epithelium. J Pathol 1999;189:201-206.
17. Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G: Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 1996;91:959-962.
18. Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Talley NJ: Helicobacter pylori infection and gastric neoplasia: Correlations with histological gastritis and tumor histology. Am J Gastroenterol 1998;93:1271-1276.
19. Haruma K, Komoto K, Kamada T, Ito M, Kitadai Y, Yoshihara M, Sumii K, Kajiyama G: Helicobacter pylori infection is a major risk factor for gastric carcinoma in young patients. Scand J Gastroenterol 2000;35:255-259.
20. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
21. Sugiyama A, Murata F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, Shimizu N, Tatematsu M: Helicobacter pylori infection enhances N-methyl-N-nitrosourea- induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 1998;58:2067-2069.
22. Tatematsu M, Yamamoto M, Shimizu N, Yoshikawa A, Fukami H Kaminishi M, Oohara T, Sugiyama A, Ikeno T: Induction of glandular stomach cancers in Helicobacter pylori-sensitive Mongolian gerbils treated with N-methyl-N-nitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine in drinking water. Jpn J Cancer Res 1998;89:97-104.
23. Watanabe T, Tada M, Nagai H, Sasaki S, Nakano M: Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998;115:642-648.
24. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Schistosomes, liver flukes, and Helicobacter pylori. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
25. Japanese Research Society for Gastric Cancer: The General Rules for Gastric Cancer Study, ed 13. Tokyo, Kinbara, 1999.
26. Bara J, Gautier R, Daher N, Zaghouani H, Decaens C: Monoclonal antibodies against oncofetal mucin M1 antigens associated with pre-cancerous colonic mucosae. Cancer Res 1986;46:3983-3989.
27. Bara J, Gautier R, Mouradian P, Decaens C, Daher N: Oncofetal mucin M1 epitope family: Characterization and expression during colonic carcinogenesis. Int J Cancer 1991;47:304-310.
28. Ishihara K, Kurihara M, Goso Y, Urata T, Ota H, Katsuyama T, Hotta K: Peripheral α-linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: Epitope recognized by a newly characterized monoclonal antibody. Biochem J 1996;318:409-416.
29. Nakamura N, Ota H, Katsuyama T, Akamatsu T, Ishihara K, Kurihara M, Hotta K: Histochemical reactivity of normal, metaplastic, and neoplastic tissues to α-linked N-acetylglucosamine residue-specific monoclonal antibody HIK1083. J Histochem Cytochem 1998;46:793-801.
30. Hertzog PJ, Robinson HC, Ma J, Mackay IR, Linnane AW: Oncofetal expression of the human intestinal mucin glycoprotein antigens in gastrointestinal epithelium defined by monoclonal antibodies. Int J Cancer 1991;48:355-363.
31. Pinczower GD, Williams RP, Gianello RD, Robinson HC, Preston BN, Linnane AW: Characterization of the tumour-associated carbohydrate epitope recognized by monoclonal antibody 4D3. Int J Cancer 1996;66:636-644.
32. Tytgat KM, Buller HA, Opdam FJ, Kim YS, Einerhand AW, Dekker J: Biosynthesis of human colon mucin: MUC2 is the prominent secretory mucin. Gasteroenterology 1994;107:1352-1363.
33. Ajioka Y, Watanabe H, Jass JR: MUC1 and MUC2 mucin in flat and polypoid colorectal adenomas. J Clin Pathol 1997;50:417-421.
34. Ajioka Y, Allison LJ, Jass JR: Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J Clin Pathol 1996;49:560-564.
35. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-1181.
36. Chen X, Haruma K, Kamada T, Mihara M, Komoto K, Yoshihara M, Sumii K, Kajiyama G: Factors that affect results of the 13C urea breath test in Japanese patients. Helicobacter 2000;5:98-103.
37. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Komoto K, Tanaka S, Kajiyama G: Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998;93:1090-1096.
38. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI: Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology: A study in relatives of patients with pernicious anemia. Gastroenterology 1982;83:204-209.
39. Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K: Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000;89:724-732.
40. Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G: Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 2001;51:165-171.
41. Kabashima A, Yao T, Sugimachi K, Tsuneyoshi M: Gastric or intestinal phenotypeic expression in the carcinomas and background mucosa of multiple early gastric carcinomas. Histopathology 2000;37:513-522.
42. Takahashi H, Endo T, Yamashita K, Arimura Y, Yamamoto H, Sasaki S, Itoh F, Hirata K, Imamura A, Kondo M, Sato T, Imai K: Mucin phenotype and microsatellite instability in early multiple gastric cancers. Int J Cancer 2002;100:419-424.
43. Katsuyama T, Spicer SS: Histochemical differentiation of complex carbohydrates with variants of the concanavalin A-horseradish peroxidase method. J Histochem Cytochem 1978;26:233-250.
44. Mcintosh GG, Lodge AJ, Watson P, Hall AG, Wood K, Anderson JJ, Angus B, Horne CH, Milton ID: NCL-CD10-270: A new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol 1999;154:77-82.
45. Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K: Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 2001;61:212-220.
46. Yao T, Kajiwara M, Kuroiwa S, Iwashita A, Oya M, Kabashima A, Tsuneyoshi M: Malignant transformation of gastric hyperplastic polyps: Alternation of phenotypes, proliferative activity, and p53 expression. Hum Pathol 2002;34:1016-1022.
47. Sasaki A, Kitadai Y, Ito M, Sumii M, Tanaka S, Yoshihara M, Haruma K, Chayama K: Helicobacter pylori infection influences tumor growth of human gastric carcinomas. Scand J Gastroenterol 2003;38:153-158.
48. Tahara E: Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993;119:265-272.
49. Endo Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, Motoyama T: Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach depend on the genetic pathways. J Pathol 2000;191:257-263.